1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. Canada >
  6. Ontario >
  7. Aralez Pharmaceuticals >
  8. M&A

Aralez Pharmaceuticals Mergers & Acquisitions

Aralez Pharmaceuticals M&A Summary

Aralez Pharmaceuticals has acquired 3 companies of its own. It has also divested 2 assets.

Aralez Pharmaceuticals’ largest acquisition to date was in 2016, when it acquired AstraZeneca - Toprol-XL for $175M. It’s largest disclosed sale occurred in 2018, when it sold Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business to Nuvo Pharmaceuticals for $110M. Aralez Pharmaceuticals has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (67%) and healthcare services (34%).

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity3
    • M&A Sell Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 1

Aralez Pharmaceuticals

Aralez Pharmaceuticals, Inc.

7100 West Credit Avenue Suite 101,
Milton, Ontario L5N 0E4
Canada,
(905) 876-1118
www.aralez.com

All (5) Buy (3) Sell (2)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2018-09-19 Aralez Pharmaceuticals, Inc. - Commercial Products & Infrastructure Pharmaceutical Business · Life Science
Milton, Ontario

Aralez Pharmaceuticals, Inc. - Commercial Products & Infrastructure Pharmaceutical Business is a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products.

110 Divestiture

Miravo Healthcare

Aralez Pharmaceuticals


Try Mergr Free — See This and 221,260+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal